Macquarie Group
BEAM icon

Macquarie Group’s Beam Therapeutics BEAM Stock Holding History

Macquarie Group’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-510
Closed -$29.1K – 2146
2022
Q2 		$20K Hold
510
– – ﹤0.01% 2304
2022
Q1 		$29 Hold
510
– – ﹤0.01% 2299
2021
Q4 		$41K Buy
510
+262
+106% +$22.4K ﹤0.01% 2215
2021
Q3 		$22K Hold
248
– – ﹤0.01% 2435
2021
Q2 		$32K Hold
248
– – ﹤0.01% 2250
2021
Q1 		$20K Sell
248
-117
-32% -$11.1K ﹤0.01% 2276
2020
Q4 		$30K Hold
365
– – ﹤0.01% 2147
2020
Q3 		$9K Hold
365
– – ﹤0.01% 2289
2020
Q2 		$10K Buy
+365
New +$7.87K ﹤0.01% 2284

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return